Helicobacter Pylori

As per available reports about 100 journals, 162 Conferences, 30 workshops are presently dedicated exclusively to Helicobacter pylori and about 366282 articles are being published on the current trends in Helicobacter pylori. In terms of research annually, USA, India, Japan, Brazil and Canada are some of the leading countries where maximum studies related to Helicobacter pylori are being carried out. As reported in Association between Helicobacter pylori Infection and Idiopathic Thrombocytopenic Purpura in Adults, Helicobacter pylori (H. pylori) are a spiral-shaped microaerophilic Gram-negative bacterium that colonizes the human gastric mucosa, and is known as a causative agent of acute and chronic gastritis. Prolonged H. pylori infection leads to gastrointestinal diseases mediated by chronic inflammation, such as atrophic gastritis, peptic ulcer, gastric hyperplastic polyp, gastric cancer and mucosa-associated lymphoid tissue (MALT) lymphoma. Although the immunological response to H. pylori infection has been suggested as a major factor involved in the gastric mucosal inflammation, it is still not clearly understood why H. pylori-infected individuals are at a high risk of development of such diverse diseases. The Journal of Blood Disorders & Transfusion is an academic journal – hosted by OMICS International – a pioneer in open access publishing–and is listed among the top 10 journals in Helicobacter pylori. Each year research scientists have noticed a rise in the number of congresses being held in this field. The Journal of Blood Disorders & Transfusion a unique platform to researchers and scientist to explore the advanced and latest research developments in the field of Helicobacter pylori, thus bridging the gap between researchers and young scientists. OMICS International – a pioneer in organizing international conferences OMICS Group scientific conferences are astonishing scientific events for the discussion and collaboration of the industrial personalities and medical professionals. Hematology-2014 is an attempt to explore a weapon against chronic diseases like blood cancer, hemophilia, lymphoma, myeloma, leukemia, sickle cell anemia etc., promising a better future for the progeny and a better vision for the springing research. Hematology 2014 is anticipated to be one amid the best scientific conferences in USA.